Health care consumer organizations and insurance companies increasingly are scrutinizing
value when considering reimbursement policies for medical interventions. Recently …

Background Sporadic multiglandular disease (MGD) has been reported in literature in 8–
33% of patients with primary hyperparathyroidism (pHPT). This paper aimed to review …

Background and aims Intraoperative parathyroid hormone assay (IOPTH) has been used
during minimally invasive parathyroidectomy (MIP) to predict operative success. However …

OBJECTIVE: To conduct a literature review on the diagnosis and management of primary
hyperparathyroidism including the classical hipercalcemic form as well as the …

Importance Intraoperative parathyroid hormone (ioPTH) is a surgical adjunct that has been
increasingly used during minimally invasive parathyroidectomy (MIP). Despite its growing …

Despite remarkable progress in imaging modalities and surgical management, persistence
or recurrence of primary hyperparathyroidism (PHPT) still occurs in 2.5–5% of cases of …

Background The majority of patients with primary hyperparathyroidism (PHPT) have a single
overactive adenoma. Advances in preoperative imaging and surgical adjuncts have given …

Parathyroidectomy (PTX) is the treatment of choice for symptomatic primary
hyperparathyroidism (PHPT). It is also the treatment of choice in asymptomatic PHPT with …

Background Primary hyperparathyroidism (PHPT) is a common endocrine disorder. In the
last few decades, the introduction of Rapid Intraoperative Parathyroid Hormone (ioPTH) …

Purpose This paper is a review of the evidence base to produce recommendations for the
use of intraoperative parathyroid hormone (PTH), radioguided parathyroidectomy (RGP) …